DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the fourteen analysts that are presently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has issued a strong buy recommendation on the […]
HM Payson & Co. raised its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 8.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,480 shares of the medical device company’s stock after buying an additional 116 shares during the quarter. HM […]
Assenagon Asset Management S.A. raised its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 1,127.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 385,295 shares of the medical device company’s stock after acquiring an additional 353,901 shares during the period. […]
Assenagon Asset Management S.A. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 1,127.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 385,295 shares of the medical device company’s stock after acquiring an additional 353,901 shares during the period. Assenagon Asset Management S.A.’s holdings in DexCom were worth $35,948,000 at […]
MGO One Seven LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,029 shares of the medical device company’s stock after selling 205 […]